The Ayurvedic medicine BGR 34 released into the market has elicited mixed reaction from the users. Among the complaints include chronic gastric problems and allergy.
BGR-34 Ayurvedic medicine for diabetes claims that it was made from medicinal plant extracts, an anti-diabetes herbal and ayurvedic drug. The company claims that it can work as a blood glucose metabolizer to protect vital organs from oxidative damage.
The ingredients mentioned on its pack show that it consists of daruharidra, vijaysar, giloy, gudmar, methika and majeeth, which it says would improve the function of the pancreas and reduces the level of glycosylated hemoglobin.
Jointly developed by the scientists of CSIR-NBRI and CSIR-CIMAP the medicine attracted immense curiosity and demand in the market as the researchers claimed 67% success during the “clinical trials” on animals. The two CSIR laboratories, National Botanical Research Institute (NBRI) and Central Institute for Medicinal and Aromatic Plant (CIMAP) — both funded by the government were behind the product’s development.
“The drug has extracts from four plants mentioned in Ayurveda and that makes it safe,” said Dr AKS Rawat, senior principal scientist, NBRI, while releasing the drug in the market. “It has been tested on animals and scientific study has found it safe and effective, with clinical trials showing 67% success,” said the scientist without giving further details.